MARATTO

article · Journal of Entomology and Zoology Studies

Efficacy of Abamectin against adult spider mite, Tetranychus cinnabarinus (Acari: Tetranychidae) on tomato in Botswana

Abstract

The efficacy of abamectin against the carmine spider mite (CSM) on tomato was studied in the laboratory at Botswana University of Agriculture and Natural Resources, Gaborone, Botswana. The acaricide was applied at five dosages including the recommended label rate. Each treatment was replicated three times. The results were analysed using probit analysis where LD50 and LD90 values found with the acaricide were estimated at different assessment periods (24, 48, 72 and 96 hours) following application and used to determine effectiveness of the acaricide. When the treatments were assessed at 24, 48, 72 and 96 h, LD90 values against spider mites were 0.82, 0.71, 0.69 and 0.64. This indicated that abamectin was highly effective against spider mites. The slopes of the probit lines assessed at 24, 48, 72 and 96 h after application were 6.68, 6.97, 6.62 and 4.46. This indicates a rapid change in mortality with increase in acaricide dosage. The study shows that abamectin can be a valuable component of integrated spider mite control programme under Botswana conditions. Further research and field testing is necessary to confirm these laboratory findings.

Research topics

  • Agricultural Practices and Plant Genetics
  • Agricultural pest management studies
  • Insect-Plant Interactions and Control

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.22271/j.ento.2022.v10.i5a.9052

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.